Senator to Investigate FDA Rejections of Rare Disease Drugs

(MedPage Today) — Sen. Ron Johnson (R-Wisc.) said Tuesday he would begin an investigation into the FDA’s handling of approval applications for biologic therapies to treat Duchenne muscular dystrophy (DMD) and other rare life-threatening disorders…

Source link : https://www.medpagetoday.com/publichealthpolicy/fdageneral/120247

Author :

Publish date : 2026-03-10 21:43:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Senator to Investigate FDA Rejections of Rare Disease Drugs

FDA Reverses Stance on Leucovorin for Autism

Tale of Two Drugs: Wegovy Linked to Higher Risk of Blinding Eye Stroke vs Ozempic

Related Posts

Palantir under fire for X ‘manifesto’ from co-founder Alex Karp

Study Sheds Light on Why Taking Vit D May Lower Diabetes Risk for Some

Study Has Warning About Missed Hepatitis B Shots at Birth

Real-World Registry Study Shows Alzheimer’s Drug Safety Outcomes

GLP-1 Drugs Make Promising Debut in TAVR, Carotid Artery Stenting

Eugene Braunwald, Cardiology Pioneer, Dies at 96

Palantir under fire for X ‘manifesto’ from co-founder Alex Karp

Study Sheds Light on Why Taking Vit D May Lower Diabetes Risk for Some

Study Has Warning About Missed Hepatitis B Shots at Birth

Real-World Registry Study Shows Alzheimer’s Drug Safety Outcomes

GLP-1 Drugs Make Promising Debut in TAVR, Carotid Artery Stenting

Eugene Braunwald, Cardiology Pioneer, Dies at 96

Cell Therapy Slows Upper Limb Decline in Duchenne Muscular Dystrophy

Potential New Target in Chronic Spontaneous Urticaria

Categories

Archives